Metformin Hydrochloride; Saxagliptin Hydrochloride is Used for improving glycemic control in adults with type 2 diabetes mellitus. It was first introduced by Astrazeneca Ab in its drug Kombiglyze Xr on Nov 5, 2010. 4 different companies have introduced drugs containing Metformin Hydrochloride; Saxagliptin Hydrochloride.

Metformin Hydrochloride; Saxagliptin Hydrochloride Patents

Given below is the list of patents protecting Metformin Hydrochloride; Saxagliptin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)

• Argentina (AR)
• Australia (AU)
• Brazil (BR)
• Canada (CA)
• Chile (CL)
• China (CN)
• India (IN)
• Japan (JP)
• Mexico (MX)
• Paraguay (PY)
• Philippines (PH)
• Russia (RU)
• Singapore (SG)
• South Africa (ZA)
• Thailand (TH)
• United States (US)
• Uruguay (UY)
• Eurasian Patent Organization (EA)
• World Intellectual Property Organization (WO)
• Taiwan (TW)
• European Patent Office (EP)

Patent Category : All

• All
• Combination
• Compound
• Device
• Dosage Regimen
• Formulation
• Other Forms
• Polymorph
• Process
• Use Method

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Kombiglyze Xr	US8628799	Coated tablet formulation and method	Jul 13, 2025 (Expired)	Astrazeneca Ab
Kombiglyze Xr	US9339472	Coated tablet formulation and method	Jul 13, 2025 (Expired)	Astrazeneca Ab
Kombiglyze Xr	USRE44186	Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method	Jul 31, 2023 (Expired)	Astrazeneca Ab
Kombiglyze Xr	US6395767	Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method	Feb 16, 2021 (Expired)	Astrazeneca Ab

Add above patents to watchlist

Metformin Hydrochloride; Saxagliptin Hydrochloride's Family Patents

Unlock Global Patents

Metformin Hydrochloride; Saxagliptin Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Metformin Hydrochloride; Saxagliptin Hydrochloride. The first generic version for Metformin Hydrochloride; Saxagliptin Hydrochloride was by Mylan Pharmaceuticals Inc and was approved on Jul 31, 2023. And the latest generic version is by Dr Reddys Laboratories Sa and was approved on Aug 9, 2023.

Given below is the list of companies who have filed for Metformin Hydrochloride; Saxagliptin Hydrochloride generic, along with the locations of their manufacturing plants worldwide.